- Category: Business
Business
Harrow purchases US commercialization rights to Samsung Bioepis' biosimilar portfolio
Acquisition includes two major anti-VEGF therapies for retinal diseases: OPUVIZ and BYOOVIZ, generic equivalents to EYLEA and Lucentis, respectively.
Business
Meta reportedly buys minority stake in EssilorLuxottica
The estimated $3.51 billion investment follows companies’ recent plans to launch AI-powered smart glasses for the Oakley sports performance frames this summer.
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
Business
4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program
Company reports streamlined planning to advance phase 3 clinical trials of 4D-150, under evaluation to deliver a single, low-dose, and sustained multi-year intravitreal injection.
Business
Alcon to purchase LumiThera
Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Business
Eyenovia rebrands as Hyperion DeFi, Inc with new focus
Name change aligns with company's pivot toward decentralized finance and focus on a cryptocurrency treasury reserve strategy; plans remain to commercialize Optejet.
Business
AOA inducts new leadership during 2025 Optometry's Meeting
Vowing pushback against vision plan abuses, Jacquie M. Bowen, OD, is named president as the 2025-2026 AOA Board of Trustees are inducted.
Business
ForSight Robotics raises $125M to advance robotic ophthalmic surgical platform
Financing to support expansion of ORYOM, the world’s first hybrid intraocular ophthalmic platform designed to deliver advanced capabilities beyond standard cataract surgery.
Business
Amaros secures Series A financing for AI ophthalmic evidence platform
Financing will support adoption and commercialization of the EvidenceEngine to accelerate clinical trial enrollment and generate real-world evidence on retinal disease.
Business
1-800 Contacts launches digital eyewear retail store
Online contact lens retailer debuts new frame and lens e-commerce shop with prescription integration, virtual and in-home try-ons, and cost-effective options.
Business
Pangaea Data's AI platform receives Topcon investment
Collaboration involves the PALLUX, which will analyze patient records against clinical guidelines and identify untreated and undiagnosed patients with ocular and systemic diseases.
Business
Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics
Funding to support two trials on fibrin-targeting immunotherapies targeting vascular dysfunction-induced neuroinflammation in severe retinal and neurological diseases.
Business
Topcon invests in MedTech startup’s microdosing drug delivery system
Collaboration involves MistGo Digital, under clinical development as a drug delivery system combined with a digital adherence monitoring platform.
Business
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
Business
Azalea Vision raises $9M to support development of intelligent ocular tech platform
Financing to support initiation of a FIH trial on the company’s smart contact lens platform; veteran ophthalmic leader appointed as chairman of the Board.
Business
Carl Zeiss Meditec AG CEO to step down
Dr. Markus Weber makes a surprise move by leaving the role at the end of May, with longtime ZEISS executive Maximilian Foerst named as successor.
Business
CORE Director Dr. Lyndon Jones to step down amid scope expansion
CORE announces integration plans into the Waterloo Eye Institute and the creation of a steering committee as it looks to expand into research of the vision system and beyond.
Business
Topcon names former Genentech exec as chief medical officer
Daniela Ferrara, MD, PhD’s role involves establishing retinal imaging as a first-line tool for both eyecare and the screening and management of complex systemic diseases.
Business
BVI Medical and Neurotech name new CCOs
With over 20 years of executive leadership experience each, Andrew Chang and Beth Marsh will lead commercialization efforts for their respective companies’ upcoming product launches.
Business